Production of serum antibodies that recognise epitopes located on the R3 region of Escherichia coli core lipopolysaccharides by patients infected with strains of enterohaemorrhagic E. coli

Journal of Medical Microbiology

Volumn 51, Issue 12, 2002, Pages 1050-1054

  Chart, Henrik ^a   Cheasty, Thomas ^a   Willshaw, Geraldine A ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; EPITOPE; LIPOPOLYSACCHARIDE; VEROTOXIN;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; BLOOD SAMPLING; CROSS REACTION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; STRAIN DIFFERENCE;

EID: 0036908503     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-51-12-1050     Document Type: Article

References (29)

1. Besser RE, Griffin PM, Slutsker L. Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: An emerging infectious disease. Annu Rev Med 1999; 50: 355-367.
2. Willshaw GA, Cheasty T, Smith HR, O'Brien SJ, Adak GK. Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995-1998. J Med Microbiol 2001; 50: 135-142.
3. Gyles C, Johnson R, Gao A et al. Association of enterohemorrhagic Escherichia coli hemolysin with serotypes of Shiga-like toxin-producing Escherichia coli of human and bovine origins. Appl Environ Microbiol 1998; 64: 4134-4141.
4. Chart H. Clinical significance of Verocytotoxin-producing Escherichia coli O157. World J Microbiol Biotech 2000; 16: 719-724.
5. Levine MM, Xu J-G, Kaper JB et al. A DNA probe to identify enterohaemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis 1987; 156: 175-182.
6. Chart H, Scotland SM, Rowe B. Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome. J Clin Microbiol 1989; 27: 285-290.
7. Chart H, Smith HR, Scotland SM, Rowe B, Milford DV, Taylor CM. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet 1991; 337: 138-140.
8. Chart H, Jenkins C. The serodiagnosis of infections caused by Verocytotoxin-producing Escherichia coli. J Appl Microbiol 1999; 86: 731-740.
9. Jenkins C, Chart H. Serodiagnosis of infection with Verocytotoxin-producing Escherichia coli. J Appl Microbiol 1999; 86: 569-575.
10. Thomas A, Chart H, Cheasty T, Smith HR, Frost JA, Rowe B. Vero cytotoxin-producing Escherichia coli particularly serogroup O157, associated with human infections in the United Kingdom: 1989-91. Epidemiol Infect 1993; 110: 591-600.
11. Thomas A, Cheasty T, Frost JA, Chart H, Smith HR, Rowe B. Vero cytotoxin-producing Escherichia coli particularly serogroup O157, associated with human infections in England and Wales: 1992-4. Epidemiol Infect 1996; 117: 1-10.
12. Chart H, Rowe B. Antibody cross-reactions with lipopolysaccharides from E. coli O157 after cholera vaccination. Lancet 1993; 341: 1282.
13. Chart H, Cheasty T, Cope D, Gross RJ, Rowe B. The serological relationship between Yersinia enterocolitica O9 and Escherichia coli O157 using sera from patients with yersiniosis and haemolytic uraemic syndrome. Epidemiol Infect 1991; 107: 349-356.
14. Chart H, Okubadejo OA, Rowe B. The serological relationship between Escherichia coli O157 and Yersinia enterocolitica O9 using sera from patients with brucellosis. Epidemiol Infect 1992; 108: 77-85.
15. Chart H, Willshaw GA, Cheasty T, Rowe B. Structure and antigenic properties of Citrobacter freundii lipopolysaccharides. J Appl Bacteriol 1993; 74: 583-587.
16. Chart H, Cheasty T, Georgiou T, Rowe B. Antigenic cross-reactions between Escherichia coli O157, Vibrio cholerae O1 (Inaba) and group N Salmonella. Serodiag Immunother Infect Dis 1993; 5: 81-84.
17. Amor K, Heinrichs DE, Frirdich E, Ziebell K, Johnson RP, Whitfield C. Distribution of core oligosaccharide types in lipopolysaccharides from Escherichia coli. Infect Immun 2000; 68: 1116-1124.
18. Currie CG, McCallum K, Poxton IR. Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease. J Med Microbiol 2001; 50: 345-354.
19. Willshaw GA, Scotland SM, Smith HR, Rowe B. Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. J Infect Dis 1992; 166: 797-802.
20. Chart H, Said B, Stokes N, Rowe B. Heterogeneity of lipopolysaccharides by strains of Escherichia coli O157. J Infect 1993; 27: 237-241.
21. Scotland SM, Willshaw GA, Smith HR, Rowe B. Properties of strains of Escherichia coli O26:H11 in relation to their enteropathogenic or enterohemorrhagic classification. J Infect Dis 1990; 162: 1069-1074.
22. Chart H, Frost JA, Oza A. Thwaites, R, Gillanders S, Rowe B. Heat-stable serotyping antigens expressed by strains of Campylobacter jejuni are probably capsular and not long-chain lipopolysaccharides. J Appl Bacteriol 1996; 81: 635-640.
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
24. Tsai C-M, Frasch CE. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 1982; 119: 115-119.
25. Currie CG, Poxton IR. The lipopolysaccharide core type of Escherichia coli O157:H7 and non-O157 verocytotoxin-producing E. coli. FEMS Immunol Med Microbiol 1999; 24: 57-62.
26. Chart H, Rowe B. Serological identification of infection by Vero cytotoxin producing Escherichia coli in patients with haemolytic uraemic syndrome. Serodiag Immunother Infect Dis 1990; 4: 413-418.
27. Sweeney EJ. Strains of Escherichia coli associated with mortality in pigs. Irish Vet J 1970; 24: 108-113.
28. Chart H, Jenkins C, Smith HR, Rowe B. Strains of Escherichia coli belonging to serogroups O157 and O55 express lipopolysaccharides that are structurally distinct and do not share common epitopes. J Infect Dis 1998; 178: 920-921.
29. Heinrichs DE, Yethon JA, Whitfield C. Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica. Mol Microbiol 1998; 30: 221-232.